REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 105 filers reported holding REVANCE THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.89 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $90,937 | -35.7% | 35,384 | +23.0% | 0.00% | – |
| Q1 2024 | $141,529 | -52.9% | 28,766 | -15.9% | 0.00% | – |
| Q4 2023 | $300,627 | -21.8% | 34,201 | +2.0% | 0.00% | – |
| Q3 2023 | $384,451 | -54.1% | 33,518 | +1.2% | 0.00% | -100.0% |
| Q2 2023 | $838,394 | -14.7% | 33,125 | +8.5% | 0.00% | 0.0% |
| Q1 2023 | $983,114 | +74.5% | 30,522 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $563,436 | -24.8% | 30,522 | +10.0% | 0.00% | 0.0% |
| Q3 2022 | $749,169 | +99.8% | 27,747 | +2.2% | 0.00% | 0.0% |
| Q2 2022 | $375,000 | -30.7% | 27,154 | -2.1% | 0.00% | 0.0% |
| Q1 2022 | $541,000 | +19.4% | 27,745 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $453,000 | -40.7% | 27,745 | +1.2% | 0.00% | -50.0% |
| Q3 2021 | $764,000 | -6.0% | 27,418 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $813,000 | +5.0% | 27,418 | -1.0% | 0.00% | 0.0% |
| Q1 2021 | $774,000 | -1.1% | 27,689 | +0.2% | 0.00% | 0.0% |
| Q4 2020 | $783,000 | +48.3% | 27,629 | +31.5% | 0.00% | +100.0% |
| Q3 2020 | $528,000 | +7.8% | 21,010 | +4.7% | 0.00% | 0.0% |
| Q2 2020 | $490,000 | +32.1% | 20,064 | -20.0% | 0.00% | 0.0% |
| Q1 2020 | $371,000 | +4.8% | 25,091 | +14.9% | 0.00% | 0.0% |
| Q4 2019 | $354,000 | +64.7% | 21,838 | +32.3% | 0.00% | – |
| Q3 2019 | $215,000 | +4.9% | 16,508 | +4.6% | 0.00% | – |
| Q2 2019 | $205,000 | -4.2% | 15,775 | +15.9% | 0.00% | – |
| Q1 2019 | $214,000 | -21.9% | 13,606 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $274,000 | -11.3% | 13,606 | +9.4% | 0.00% | 0.0% |
| Q3 2018 | $309,000 | -9.4% | 12,433 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $341,000 | +6.6% | 12,433 | +19.6% | 0.00% | 0.0% |
| Q1 2018 | $320,000 | -14.0% | 10,392 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $372,000 | +30.1% | 10,392 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $286,000 | +4.4% | 10,392 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $274,000 | +35.6% | 10,392 | +75.5% | 0.00% | – |
| Q4 2015 | $202,000 | -16.5% | 5,920 | -21.9% | 0.00% | -100.0% |
| Q2 2015 | $242,000 | – | 7,579 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NQ HCIF GP, Ltd. | 3,096,650 | $52,457,000 | 100.00% |
| Essex Woodlands Management, Inc. | 4,592,047 | $77,789,000 | 24.28% |
| Rhenman & Partners Asset Management AB | 126,574 | $2,144,000 | 0.62% |
| Polar Capital LLP | 1,107,272 | $18,756,000 | 0.37% |
| ArrowMark Colorado Holdings LLC | 787,923 | $13,347,000 | 0.34% |
| Lombard Odier Asset Management (USA) Corp | 250,605 | $4,245,000 | 0.29% |
| Visium Asset Management, LP | 1,000,000 | $16,940,000 | 0.24% |
| C Partners Holding GmbH | 24,000 | $407,000 | 0.13% |
| NOTTINGHAM ADVISORS, INC. | 23,018 | $390,000 | 0.10% |
| WALL STREET ASSOCIATES | 57,330 | $971,000 | 0.09% |